Abstract
Non-urogenital Mycoplasma hominis infections are rare, but may cause life-threatening complications. We describe a case of disseminated M. hominis infection with extensive abscess formation in an immunocompromised patient with iatrogenic hypogammaglobulinemia under rituximab treatment.
References
CLSI. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; Approved Guideline. CLSI document MM18-A. Wayne: Clinical and Laboratory Standards Institute. 2008.
Pailhories H, Rabier V, Eveillard M, Mahaza C, Joly-Guillou M-L, Chennebault J-M, Kempf M, Lemarie C. A case report of Mycoplasma hominis brain abscess identified by MALDI-TOF mass spectrometry. Int J Infect Dis. 2014;29:166–8.
Fenollar F, Gauduchon V, Casalta J-P, Lepidi H, Vandenesch F, Raoult D. Mycoplasma endocarditis: two case reports and a review. Clin Infect Dis. 2004;38:e21–4.
Miana AN, Farney AC, Mendleya SR. Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature. Am J Transplant. 2005;5:183–8.
MacKenzie CR, Nischik N, Kram R, Krauspe R, Jäger M, Henrich B. Fatal outcome of a disseminated dual infection with drug-resistant Mycoplasma hominis and Ureaplasma parvum originating from a septic arthritis in an immunocompromised patient. Int J Infect Dis. 2010;14(Suppl 3):e307–9.
Wylam ME, Kennedy CC, Hernandez NM, Peters SG, Maleszewski JJ, Cassivi SD, Scott JP. Fatal hyperammonaemia caused by Mycoplasma hominis. Lancet. 2013;382:1956.
Meyer RD, Clough W. Extragenital Mycoplasma hominis infections in adults: emphasis on immunosuppression. Clin Infect Dis. 1993;17:S243–9.
Irie E, Shirota Y, Suzuki C, Tajima Y, Ishizawa K, Kameoka J, Harigae H, Ishii T. Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis. Int J Hematol. 2010;91:501–8.
Gdoura R, Kchaou W, Chiraz Chaari C, Abir Znazen A, Leila Keskes L, Tarek Rebai T, Hammami A. Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men. BMC Infect Dis. 2007;7:129.
Waites KB, Crabb DM, Duffy LB. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human Mycoplasmas and Ureaplasmas. Antimicrob Agents Chemother. 2008;10:3776–8.
Krausse R, Schubert S. In-Vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. Isolated in Germany over 20 years. Clin Microbiol Infect. 2010;16:1649–55.
Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones. Antimicrob Agents Chemother. 2001;45:2604–8.
Pereyre S, Tardy F, Renaudin H, Cauvin E, del Prá Netto Machado L, Tricot A, Benoit F, Treilles M, Bébéar C. Identification and subtyping of clinically relevant human and ruminant Mycoplasmas by use of matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol. 2013;51:3314–23.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Nulens, E., Van Praet, J., Selleslag, D. et al. A disseminated Mycoplasma hominis infection in a patient with an underlying defect in humoral immunity. Infection 44, 379–381 (2016). https://doi.org/10.1007/s15010-015-0859-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-015-0859-6